TY  - CONF

T1  - Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study

JO  - EUROPEAN HEART JOURNAL

PY  - 1998/04/01

AU  - van Hout BA

AU  - Bowman L

AU  - Zelinger DJ

AU  - Simoons ML

ED  - 

VL  - 19

SP  - D59

EP  - D66

Y2  - 2024/10/22

ER  -